Blood test may replace needles for endometrial cancer monitoring
NCT ID NCT05049538
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing whether a blood test, called a liquid biopsy, can find cancer cells and predict if endometrial cancer will return. Researchers will collect blood and tissue samples from 1,000 women with endometrial cancer before and after treatment. The goal is to see if this non-invasive test works as well as or better than standard tissue biopsies for tracking the cancer.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENDOMETRIAL CLEAR CELL ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
M D Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Digital therapy aims to tame the fear that haunts cancer survivors
- New PET tracer could spot cancers that standard scans overlook
- Common diabetes and acne drugs tested against cancer
- New scan and dye combo may spot hidden cancer in lymph nodes
- Experimental drug triapine tested in rare uterine cancer before surgery
- Blood test may help cancer patients avoid nerve damage from chemo